{"id":"W4389621900","doi":"10.1681/asn.0000000000000274","title":"The Improved Kidney Risk Score in ANCA-Associated Vasculitis for Clinical Practice and Trials","year":2023,"lang":"en","type":"article","venue":"Journal of the American Society of Nephrology","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Medical Research Council; Genentech; Sangamo Therapeutics; Sanofi; Renal Pathology Society; Canadian Institute for Theoretical Astrophysics; Celltrion; Wellcome Trust; Alexion Pharmaceuticals; Amgen; Vifor Pharma; Pfizer; Omeros Corporation; Health Service Executive; Fresenius Medical Care North America; AstraZeneca; Eli Lilly and Company; GlaxoSmithKline","keywords":"ANCA-Associated Vasculitis; Medicine; Internal medicine; Clinical Practice; Vasculitis; Clinical trial; Physical therapy; Disease","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":{"n_in":0,"stratum":"fund_new","weight":1678.9,"opus":{"tier":"OUT","genre":"empirical","about_ca":false,"confidence":"high","reason":"Development and validation of a clinical kidney risk prediction score in ANCA-associated vasculitis; a clinical prognostic tool, not a study of research practice."},"gpt":{"tier":"OUT","genre":"empirical","about_ca":false,"confidence":"high","reason":"The study develops and validates a clinical risk score for ANCA-associated vasculitis."},"grok":{"tier":"OUT","genre":"empirical","about_ca":false,"confidence":"high","reason":"Clinical prognostic score for ANCA-associated kidney disease; object is disease risk, not trial methodology."}},"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.07871943,0.00104121,0.002476056,0.002624849,0.0004300349,0.004077366,0.001525998,0.001747221,0.007212561],"category_scores_gemma":[0.245885,0.0004014812,0.002353075,0.004678906,0.00065102,0.00210944,0.002574114,0.002435812,0.001983717],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001920624,"about_ca_system_score_gemma":0.00643333,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000935704,"about_ca_topic_score_gemma":0.00186817,"domain_scores_codex":[0.9192156,0.05952666,0.008882583,0.002501916,0.008786377,0.00108687],"domain_scores_gemma":[0.7746013,0.1216059,0.0511547,0.01560035,0.02907887,0.007958835],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0128395,0.000349762,0.3047733,0.007086046,0.00815053,0.0003303764,0.0003287506,0.01294944,0.0007613804,0.005744782,0.1545146,0.4921715],"study_design_scores_gemma":[0.02402314,0.007732312,0.557215,0.008251682,0.01397172,0.002560067,0.000286838,0.1866231,0.002468806,0.03378237,0.1624295,0.000655522],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.3664156,0.09423092,0.2153533,0.1770317,0.01605633,0.01930059,0.05398866,0.005797748,0.05182523],"genre_scores_gemma":[0.7589159,0.01041254,0.175706,0.01043126,0.006758562,0.01349497,0.01952803,0.0004409675,0.004311666],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07871943,"threshold_uncertainty_score":0,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05067553353311106,"score_gpt":0.3822858783854226,"score_spread":0.3316103448523115,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}